Check Cap (CHEK) announced that it has closed its direct placement of equity with an institutional investor. The $6M deal includes 643,614 ordinary shares at $1.90 plus 2,514,281 pre-funded seven-year warrants ($1.85) to purchase ordinary shares at $0.05. Net proceeds from the offering will fund ongoing clinical development of its colorectal cancer screening system and general corporate purposes.